The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effect of the microbiome on immune checkpoint inhibitor toxicity in patients with melanoma.
 
Nyelia Williams
No Relationships to Disclose
 
Rebecca Hoyd
No Relationships to Disclose
 
Caroline E. Wheeler
No Relationships to Disclose
 
Mari Lynn
No Relationships to Disclose
 
Amna Bibi
No Relationships to Disclose
 
Shannon Gray
No Relationships to Disclose
 
Michael Bodner
No Relationships to Disclose
 
Namrata Arya
No Relationships to Disclose
 
Scott Roberts
No Relationships to Disclose
 
Phuong Hoang
No Relationships to Disclose
 
Jessica Apparicio
No Relationships to Disclose
 
Deanna Merrill
No Relationships to Disclose
 
Richard Cheng Han Wu
Research Funding - Iovance Biotherapeutics (Inst)
 
Claire F. Verschraegen
No Relationships to Disclose
 
Christin Elizabeth Burd
Stock and Other Ownership Interests - Abbvie; GE Healthcare; Gilead Sciences; Gilead Sciences; Luminex
Patents, Royalties, Other Intellectual Property - Licensing of cell lines to Millipore
 
Kari Lynn Kendra
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); GlaxoSmithKline (Inst); Idera (Inst); Immunocore (Inst); Isarti Oncology (Inst); Merck (Inst); Novartis (Inst)
 
Daniel Spakowicz
No Relationships to Disclose